Eric McLaughlin

706 total citations
61 papers, 396 citations indexed

About

Eric McLaughlin is a scholar working on Oncology, Surgery and Pathology and Forensic Medicine. According to data from OpenAlex, Eric McLaughlin has authored 61 papers receiving a total of 396 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Oncology, 12 papers in Surgery and 11 papers in Pathology and Forensic Medicine. Recurrent topics in Eric McLaughlin's work include Lymphoma Diagnosis and Treatment (7 papers), Chronic Lymphocytic Leukemia Research (6 papers) and T-cell and Retrovirus Studies (4 papers). Eric McLaughlin is often cited by papers focused on Lymphoma Diagnosis and Treatment (7 papers), Chronic Lymphocytic Leukemia Research (6 papers) and T-cell and Retrovirus Studies (4 papers). Eric McLaughlin collaborates with scholars based in United States, Saudi Arabia and Malaysia. Eric McLaughlin's co-authors include Xiaoli Zhang, Marco Mineo, Isabel DeLaura, Quazim A. Alayo, John A. McNulty, Hirotaka Ito, David A. Reardon, Electra D. Paskett, Korneel Grauwet and William F. Goins and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Eric McLaughlin

51 papers receiving 394 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eric McLaughlin United States 10 213 113 81 69 49 61 396
Joerg Krueger Canada 12 192 0.9× 75 0.7× 77 1.0× 103 1.5× 67 1.4× 59 463
Alicia M. Waters United States 13 153 0.7× 132 1.2× 140 1.7× 37 0.5× 68 1.4× 29 381
Taro Okayama Japan 11 114 0.5× 72 0.6× 89 1.1× 101 1.5× 21 0.4× 24 490
Lixia Zhu China 13 107 0.5× 113 1.0× 57 0.7× 108 1.6× 16 0.3× 54 427
Lauren Weintraub United States 11 72 0.3× 118 1.0× 52 0.6× 63 0.9× 82 1.7× 28 408
Alexander Zukiwski United States 11 97 0.5× 97 0.9× 48 0.6× 55 0.8× 54 1.1× 26 335
Michèle Oster France 9 72 0.3× 114 1.0× 48 0.6× 109 1.6× 37 0.8× 9 438
Silvy Lachance Canada 15 240 1.1× 118 1.0× 35 0.4× 178 2.6× 86 1.8× 67 616
Matthew Ming Kong Shing Hong Kong 14 97 0.5× 171 1.5× 56 0.7× 52 0.8× 49 1.0× 32 515

Countries citing papers authored by Eric McLaughlin

Since Specialization
Citations

This map shows the geographic impact of Eric McLaughlin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric McLaughlin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric McLaughlin more than expected).

Fields of papers citing papers by Eric McLaughlin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric McLaughlin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric McLaughlin. The network helps show where Eric McLaughlin may publish in the future.

Co-authorship network of co-authors of Eric McLaughlin

This figure shows the co-authorship network connecting the top 25 collaborators of Eric McLaughlin. A scholar is included among the top collaborators of Eric McLaughlin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric McLaughlin. Eric McLaughlin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Brammer, Jonathan E., Zachary Braunstein, Patrick Stevens, et al.. (2025). Targeting the methylome in T-LGL leukemia: Pre-clinical analysis and Results of a Phase I trial with oral 5-azacytidine. Blood. 146(Supplement 1). 890–890.
2.
Braunstein, Zachary, et al.. (2024). Short-course subcutaneous alemtuzumab induces clinical responses in relapsed T-cell large granular leukemia. Haematologica. 110(4). 995–998. 1 indexed citations
3.
McLaughlin, Eric, et al.. (2024). Intravenous Ketamine for Cancer Pain: A Single-Center Retrospective Analysis Comparing Fixed-Rate Versus Weight-Based Dosing. Journal of Pain & Palliative Care Pharmacotherapy. 38(4). 414–422.
4.
Shieh, Christine, Henry J. Thompson, Eric McLaughlin, Chien‐Wei Chiang, & Hisham Hussan. (2024). Advancements in Understanding and Preventing Obesity-Related Colon Cancer. The Cancer Journal. 30(5). 357–369. 1 indexed citations
5.
McLaughlin, Eric, et al.. (2023). Opioid Risk Mitigation Practices of Interprofessional Oncology Personnel: Results From a Cross-Sectional Survey. The Oncologist. 28(11). 996–1004. 2 indexed citations
6.
Krok‐Schoen, Jessica L., Michelle J. Naughton, Ashley S. Felix, et al.. (2023). Resiliency Among Women’s Health Initiative Women Aged 80 and Older by Race, Ethnicity, and Neighborhood Socioeconomic Status. The Journals of Gerontology Series B. 78(9). 1445–1458. 4 indexed citations
7.
Barac, Ana, Theodore M. Brasky, Aladdin H. Shadyab, et al.. (2023). Pre‐diagnosis lipid levels and mortality after obesity‐related cancer diagnosis in the Women's Health Initiative cardiovascular disease biomarker cohort. Cancer Medicine. 12(15). 16626–16636. 5 indexed citations
8.
Brammer, Jonathan E., Karen K. Ballen, Lubomir Sokol, et al.. (2023). Effective treatment with the selective cytokine inhibitor BNZ-1 reveals the cytokine dependency of T-LGL leukemia. Blood. 142(15). 1271–1280. 12 indexed citations
9.
Doepker, Bruce, et al.. (2023). Impact of initial fluid resuscitation volume on clinical outcomes in patients with heart failure and septic shock. SHILAP Revista de lepidopterología. 3(3). 254–260. 1 indexed citations
10.
Braunstein, Zachary, Eric McLaughlin, Walter Hanel, et al.. (2023). Gemcitabine and liposomal doxorubicin (GemDox) for the treatment of relapsed and refractory T-cell lymphomas. Leukemia & lymphoma. 65(3). 301–311. 1 indexed citations
11.
Berger, Michael, et al.. (2023). Effect of Concurrent Proton Pump Inhibitors With Palbociclib Tablets for Metastatic Breast Cancer. Clinical Breast Cancer. 23(6). 658–663. 8 indexed citations
12.
13.
Reardon, Joshua, et al.. (2022). First-line gemcitabine plus nab-paclitaxel versus FOLFIRINOX for metastatic pancreatic cancer in a real-world population. Future Oncology. 18(20). 2521–2532. 4 indexed citations
14.
15.
Kamgar, Mandana, Mark K. Greenwald, Theresa A. Hastert, et al.. (2021). Prevalence and predictors of peripheral neuropathy after breast cancer treatment. Cancer Medicine. 10(19). 6666–6676. 30 indexed citations
16.
Selmic, Laura E., Ryan Jennings, Eric McLaughlin, et al.. (2021). Diagnostic accuracy of optical coherence tomography for surgical margin assessment of feline injection‐site sarcoma. Veterinary and Comparative Oncology. 19(4). 632–640. 4 indexed citations
17.
Eiferman, Daniel, et al.. (2020). Combating the Opioid Epidemic in Acute General Surgery: Reframing Inpatient Acute Pain Management. Journal of Surgical Research. 251. 6–15. 6 indexed citations
18.
Liu, Lu, Shurui Cai, Chunhua Han, et al.. (2019). ALDH1A1 Contributes to PARP Inhibitor Resistance via Enhancing DNA Repair in BRCA2−/− Ovarian Cancer Cells. Molecular Cancer Therapeutics. 19(1). 199–210. 51 indexed citations
19.
Mikhail, Irene, et al.. (2019). Change in Peanut Skin Prick Testing Over Time in Infants at Risk for Food Allergy Who Continue to Avoid Peanut. Journal of Allergy and Clinical Immunology. 143(2). AB261–AB261. 1 indexed citations
20.
Passaro, Carmela, Quazim A. Alayo, Isabel DeLaura, et al.. (2018). Arming an Oncolytic Herpes Simplex Virus Type 1 with a Single-chain Fragment Variable Antibody against PD-1 for Experimental Glioblastoma Therapy. Clinical Cancer Research. 25(1). 290–299. 103 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Joerg Krueger Breakdown of academic impact, for papers by Alicia M. Waters Breakdown of academic impact, for papers by Taro Okayama Breakdown of academic impact, for papers by Lixia Zhu Breakdown of academic impact, for papers by Lauren Weintraub Breakdown of academic impact, for papers by Alexander Zukiwski Breakdown of academic impact, for papers by Michèle Oster Breakdown of academic impact, for papers by Silvy Lachance Breakdown of academic impact, for papers by Matthew Ming Kong Shing
Rankless by CCL
2026